(untitled)
Andrew Lin(Baker Heart and Diabetes Institute), Damini Dey(Cedars-Sinai Medical Center), Nipun Manral(Cedars-Sinai Medical Center), Aakash Shanbhag(Cedars-Sinai Medical Center), Kajetan Grodecki(Cedars-Sinai Medical Center), Markus Goeller(Friedrich-Alexander-Universität Erlangen-Nürnberg), Mohamed Marwan(Friedrich-Alexander-Universität Erlangen-Nürnberg), Konrad Pieszko(Cedars-Sinai Medical Center), Aditya Killekar(Cedars-Sinai Medical Center), Michelle C. Williams(University of Edinburgh), Stephan Achenbach(Friedrich-Alexander-Universität Erlangen-Nürnberg), Guadalupe Flores Tomasino(Cedars-Sinai Medical Center), Donghee Han(Cedars-Sinai Medical Center), Heidi Gransar(Cedars-Sinai Medical Center), Stephen J. Nicholls(Australian Centre for Heart Health), Hidenari Matsumoto(SHOWA Medical University), Mhairi Doris(MACOM (United States)), Sebastien Cadet(Cedars-Sinai Medical Center), Jacek Kwieciński(MACOM (United States)), Marc R. Dweck(University of Edinburgh), Aryabod Razipour(Cedars-Sinai Medical Center), David E. Newby(University of Edinburgh), Priscilla McElhinney(Cedars-Sinai Medical Center), Balaji Tamarappoo(Cedars-Sinai Medical Center), Piotr J. Slomka(Cedars-Sinai Medical Center), Keiichiro Kuronuma(Cedars-Sinai Medical Center), Daniel S. Berman(Cedars-Sinai Medical Center), Caroline Park(Cedars-Sinai Medical Center), Dennis Wong(Monash Health), Alan C. Kwan(Cedars-Sinai Medical Center), Yuka Otaki(Cedars-Sinai Medical Center), Evangelos Tzolos(University of Edinburgh)
Edinburgh Research Explorer (University of Edinburgh)
January 1, 2000
Cited by 233
Related Papers
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome
|New England Journal of Medicine|2012|2k
SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe
|European Heart Journal|2021|1.7k